Qulipta
NDC 0074-7095, Atogepant, tablet, from AbbVie Inc..
- Product NDC
- 0074-7095
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215206
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOGEPANT10 mg/1
Pharmacologic classes
Calcitonin Gene-related Peptide Receptor Antagonist [EPC]; Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-7095-30 | 00074709530 | 30 TABLET in 1 BOTTLE (0074-7095-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8c8ab8f4-32bd-497a-befa-70c8a51d8d52NADAC price for package 00074709530
GET /v1/drugs/nadac/00074709530
Use it
Look up 0074-7095 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-7095. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.